Figur8
Boston, US · 9 known investors
FIGUR8 is an FDA-registered platform that provides objective, actionable insights for musculoskeletal health diagnosis and treatment. The platform originated from collaboration between MIT scientists, Massachusetts General Hospital, and the Boston Red Sox, and is now adapted for use across any point of care.
AI & Machine LearningHardwareHealthtechMedical Devices
Founders & leadership
NG

Nan-Wei GonginCEO and Founder
Investors · 9
First Spark Ventures, Llc✓ verifiedMenlo Park
Phoenix Venture Partners✓ verifiedSan Mateo · $100K – $3M
Chloe CapitalIthaca · $100K – $250K
DigiTx Partners LLCSan Francisco · $2M – $5M
Evolution VC PartnersNew York
GRIDS CapitalSão Paulo
P5 Health VenturesWestport
Taiwan Global AngelsBerkeley · $300K – $3M
The E14 FundCambridge · $1M – $5M
Competitors · 3
by search overlapFigure8 shared keywordsFigure is a lending platform that offers residential and commercial loan products including home equity lines of credit, cash-out refinances, DSCR loans, and crypto-backed loans for borrowers.
Figure AI7 shared keywordsFigure develops general-purpose humanoid robots designed for deployment in workforce and home environments. The company builds commercial-grade robotic systems with advancing dexterity and autonomy capabilities.
Biomech Holdings7 shared keywordsBioMech develops wireless, noninvasive motion sensors and analytics software (BioMech Lab and BioMech AI) that capture and stream three-dimensional motion in real time. Its platform serves healthcare, sports/wellness, and industrial markets to quantify and improve movement outcomes.
Companies competing with Figur8 for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase ISTTR | 2021 | $150K |
| U.S. Air ForceAir Force | Phase I | 2020 | $50K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Figur8 do?
- FIGUR8 is an FDA-registered platform that provides objective, actionable insights for musculoskeletal health diagnosis and treatment. The platform originated from collaboration between MIT scientists, Massachusetts General Hospital, and the Boston Red Sox, and is now adapted for use across any point of care.
- Who founded Figur8?
- Figur8 was founded by Nan-Wei Gong.
- Who are Figur8's investors?
- Figur8's investors include First Spark Ventures, Llc, Phoenix Venture Partners, Chloe Capital, DigiTx Partners LLC, Evolution VC Partners, GRIDS Capital, P5 Health Ventures, Taiwan Global Angels and 1 more.
- Where is Figur8 headquartered?
- Figur8 is headquartered in Boston, US.


